Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Krishna Institute of Medical Sciences Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Krishna Institute of Medical Sciences Ltd trades at a P/E of 132.73× and P/B of 14.21×.
Valuation
Profitability
Growth
Financial Health
Krishna Institute of Medical Sciences Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Krishna Institute of Medical Sciences Ltd, switchable between annual and quarterly views, consolidated or standalone.
Krishna Institute of Medical Sciences Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹31,608.98 Cr and reported EPS of ₹6.00.
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 |
| Other Income | 10 | 20 | 26 | 13 | 32 | 26 |
| Total Income | 1,340 | 1,671 | 2,224 | 2,511 | 3,067 | 3,931 |
| Cost of Goods Sold (COGS) | 289 | 355 | 481 | 530 | 627 | 809 |
| Gross Profit | 1,041 | 1,296 | 1,717 | 1,968 | 2,408 | 3,096 |
| +Operating Expenses | 670 | 780 | 1,113 | 1,327 | 1,625 | 2,294 |
| EBITDA | 371 | 516 | 604 | 640 | 783 | 802 |
| +Non-Operating Expenses | 102 | 89 | 175 | 194 | 278 | 475 |
| Profit Before Tax (PBT) | 279 | 447 | 485 | 460 | 558 | 331 |
| +Tax Expense | 74 | 114 | 119 | 124 | 143 | 92 |
| Profit After Tax (PAT) | 205 | 344 | 366 | 336 | 415 | 242 |
| Earnings Per Share (EPS) | 5.03 | 8.31 | 8.41 | 7.75 | 9.61 | 6.03 |
| Diluted Shares Outstanding (Nos.) | 40 | 40 | 40 | 40 | 40 | 40 |
| +Additional Disclosures | 1,354 | 1,600 | 2,264 | 2,607 | 3,175 | 4,401 |
| Sales Growth % | — | 24.13 | 33.13 | 13.67 | 21.49 | 28.65 |
| YoY Sales Growth % | — | 24.13 | 33.13 | 13.67 | 21.49 | 28.65 |
| Material Cost % | 21 | — | — | — | — | — |
| Employee Cost % | 17 | 16 | 16 | 17 | 16 | 17 |
| Other Cost % | 34 | 31 | 35 | 36 | 37 | 41 |
| OPM % | 28 | 31 | 27 | 26 | 26 | 21 |
| Tax % | 26 | 26 | 25 | 27 | 26 | 28 |
| Profit Growth % | — | 67.31 | 6.40 | -8.15 | 23.45 | -41.66 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 301 | 443 | 475 | 494 | 606 | 519 |
Krishna Institute of Medical Sciences segment analysis: revenue and profit mix.
Disclosed business segments at Krishna Institute of Medical Sciences with their share of revenue and profit, switchable between consolidated and standalone reporting.
Krishna Institute of Medical Sciences discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Krishna Institute of Medical Sciences Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Krishna Institute of Medical Sciences Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Krishna Institute of Medical Sciences Ltd's investment case rests on 5 positive markers and 7 flagged concerns drawn from the latest reported filings.
What you're getting.
KIMS demonstrates strong financial efficiency with an 18.5% Return on Equity (ROE) and a healthy 15.0% Return on Capital Employed (ROCE). This indicates effective utilization of shareholder funds, driving robust profitability and sound capital management.
KIMS achieved robust quarterly sales growth, reporting a significant 26.6% increase. This positive trend indicates strong market demand and successful expansion strategies, contributing to the company's financial health and future growth potential.
KIMS maintains a strong operating profit margin (OPM) of 24.7%, demonstrating its ability to generate substantial profits from core operations. This resilience, even amidst market fluctuations, is a key indicator of the company's financial strength and stability.
The healthcare sector, where KIMS operates, is poised for significant growth driven by an aging population, increasing health awareness, and rising disposable incomes. This provides a substantial market expansion opportunity for KIMS.
KIMS, with a market cap of ₹29,400 Cr, is smaller than major peers like Max Healthcare (₹115,613 Cr). This indicates significant potential for market share expansion and growth within the competitive healthcare sector.
What can break it.
KIMS's high Price-to-Earnings (PE) ratio of 79.70 suggests the stock might be overvalued relative to its earnings. This is higher than peers like Narayana Hrudaya (46.54), potentially posing a risk and warrants careful consideration.
The company's debt-to-equity ratio of 1.20 indicates a relatively high level of debt compared to equity. This leverage could increase financial risk, especially during economic downturns or periods of reduced profitability.
Promoter holding is 34.1%, a decline from 38.85% in 2022. This reduction could potentially raise concerns about shareholding confidence, making it crucial to monitor future changes for overall stability.
KIMS reported a quarterly profit decline of -9.24%, indicating some variability in recent earnings. This negative trend in profitability warrants attention, as sustained declines could impact investor confidence and future growth prospects.
The highly competitive healthcare sector, with established players like Apollo Hospitals and Max Healthcare, poses a significant threat. Intense competition could pressure KIMS's pricing power and market share, impacting future profitability.
What would change my mind.
Trim if P/E re-rates above 173. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 166.73. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Krishna Institute of Medical Sciences Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Krishna Institute of Medical Sciences Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Krishna Institute of Medical Sciences Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Krishna Institute of Medical Sciences Ltd — derived from the live tape, not yesterday's close.
Krishna Institute of Medical Sciences Ltd last traded at ₹789.75 with an intraday range of ₹784.55–₹804.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹789.75| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 842.02 | +52.27 | +6.62% |
| R3 | 821.77 | +32.02 | +4.05% |
| R2 | 813.28 | +23.53 | +2.98% |
| R1 | 801.52 | +11.77 | +1.49% |
| PIVOT | 793.03 | 3.28 | 0.42% |
| CURRENT | 789.75 | — | — |
| S1 | 740.77 | -48.98 | -6.20% |
| S2 | 761.02 | -28.73 | -3.64% |
| S3 | 772.78 | -16.97 | -2.15% |
| S4 | 781.27 | -8.48 | -1.07% |
KIMS is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 784.55 ~ 796.75
Trading Inside opening range
Krishna Institute of Medical Sciences Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Krishna Institute of Medical Sciences Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Krishna Institute of Medical Sciences Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Krishna Institute of Medical Sciences Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Krishna Institute of Medical Sciences Ltd stood at 48.1% of traded volume, against a 20-day average of 47.6%.
Krishna Institute of Medical Sciences announcements: results, concalls, ratings, M&A.
Filings Krishna Institute of Medical Sciences sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Krishna Institute of Medical Sciences files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 135 documents below.
Outcome of Board Meeting
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 13, 2026.
Disclosure under SEBI Takeover Regulations
Dr. Bhaskara Rao Bollineni has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial…
Analysts/Institutional Investor Meet/Con. Call Updates
Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
Press Release
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 16, 2026, titled "Press Release".
Investor decks & rating reports.
Krishna Institute of Medical Sciences dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Krishna Institute of Medical Sciences has declared, sequenced by announce and record date.
Krishna Institute of Medical Sciences corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Krishna Institute of Medical Sciences Ltd: business, sector, key facts.
What Krishna Institute of Medical Sciences Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Krishna Institute of Medical Sciences Ltd operates in the Healthcare, listed as NSE: KIMS, BSE: 543308.
KIMS Hospitals, officially Krishna Institute of Medical Sciences Limited, is a prominent healthcare provider in India, operating under the KIMS Hospitals brand. Their business centers on delivering a comprehensive range of medical and healthcare services across numerous specialties. This wide-ranging approach allows them to cater to a diverse patient population with varied healthcare needs.
The company's service offerings span a broad spectrum of medical disciplines. Key specialties include cardiology, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgery. Beyond these core areas, KIMS also provides services in gastroenterology and hepatology, heart and lung transplants, other organ transplantation procedures, mother and childcare, and pediatrics. This comprehensive approach ensures a wide array of patient needs can be addressed within their facilities.
Further specializing their services, KIMS focuses on areas such as accident and emergency care, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, and Alzheimer's disease management. They also possess expertise in various specialized centers, including bone and joint centers. This detailed specialization allows for targeted expertise and advanced treatment options in specific medical fields.
The breadth of their procedural capabilities is equally impressive. KIMS performs a wide variety of medical procedures, including those related to aneurysms, ankle arthritis and replacements, cervical discectomies and fusions, anterior resections, aortic aneurysms and stent grafts, aortic valve replacements, arthroscopies, atrial septal defects, and bariatric surgeries. This extensive procedural capacity demonstrates a high level of technological and surgical proficiency.
Established in 1973 and headquartered in Secunderabad, India, KIMS Hospitals has a long history of providing healthcare services within the country. Their continued growth and expansion into diverse medical specialties highlights their commitment to providing advanced and comprehensive healthcare solutions to the Indian population.
Questions investors ask about Krishna Institute of Medical Sciences Ltd (KIMS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Krishna Institute of Medical Sciences Ltd (KIMS)?
The current share price of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹789.75. Today, the stock has declined by ₹6.65 (0.84%), trading in a range of ₹784.55 to ₹804.8. The stock opened at ₹795 with a trading volume of 4,53,927 shares.
02Is Krishna Institute of Medical Sciences Ltd stock a good investment for long-term?
Krishna Institute of Medical Sciences Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹31,608.98 crores, P/E ratio of 132.73, ROE of 9.72%, and ROCE of 15.00%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Krishna Institute of Medical Sciences Ltd stock?
The 52-week high price of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹811, while the 52-week low is ₹575.8. Currently trading at ₹789.75, the stock is 91.0% away from its 52-week low and 2.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Krishna Institute of Medical Sciences Ltd stock at the current price?
Whether to buy Krishna Institute of Medical Sciences Ltd stock at ₹789.75 depends on multiple factors. The stock is currently trading with a P/E ratio of 132.73 and P/B ratio of 14.21. Today's performance shows a loss of 0.84%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Krishna Institute of Medical Sciences Ltd and when is the next dividend?
Krishna Institute of Medical Sciences Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹789.75, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd's key financial metrics include: P/E Ratio: 132.73, P/B Ratio: 14.21, ROE: 9.72%, ROCE: 15.00%, Dividend Yield: 0.00%, EPS: ₹6.00, Book Value: ₹56.05, and Debt-to-Equity: 166.23. The company's market cap stands at ₹31,608.98 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Krishna Institute of Medical Sciences Ltd stock performing today in the market?
Krishna Institute of Medical Sciences Ltd stock opened at ₹795 and is currently trading at ₹789.75, showing a decline of ₹6.65 (0.84%). The intraday high is ₹804.8 and low is ₹784.55. The trading volume stands at 4,53,927 shares, indicating moderate market participation today.
08What is the P/E ratio of Krishna Institute of Medical Sciences Ltd and what does it indicate?
Krishna Institute of Medical Sciences Ltd has a Price-to-Earnings (P/E) ratio of 132.73, which means investors are willing to pay ₹132.73 for every ₹1 of earnings. With an EPS of ₹6.00, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Krishna Institute of Medical Sciences Ltd (KIMS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwals Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy